NOVEMBER 21, 2017
Glytec to Present at 29th Annual Piper Jaffray Healthcare Conference
The invitation-only event is being held in New York City at the Lotte New York Palace Hotel.
Waltham, MA — Glytec President and CEO, Bob Leonard, will present an update on the company at the 29th Annual Piper Jaffray Healthcare Conference, Wednesday, November 29, 2017, 3:00 pm EST. The invitation-only event is being held in New York City at the Lotte New York Palace Hotel.
Founded in 2006, Glytec is the pioneer of personalized digital therapeutics. The company’s patented and FDA-cleared software-as-a-medical-device solutions improve the safety and health of people with diabetes and make insulin a more effective and accessible medication option for millions who are unable to achieve their treatment goals. Glytec combines evidence-based decision support technologies with expert clinical services to optimize basal and bolus insulin therapies in the hospital and at home, and in turn reduce hypoglycemia and other complications as well as avoidable ED visits, hospitalizations, readmissions and drug waste. For more information visit www.glytecsystems.com.